Long-Acting Injectable Therapy for People with HIV: Looking Ahead with Lessons from Psychiatry and Addiction Medicine
Gabriel G. Edwards, Ayako Miyashita-Ochoa, Enrico G. Castillo, David Goodman‐Meza, Ippolytos Kalofonos, Raphael J. Landovitz, Arleen Leibowitz, Craig Pulsipher, Ed El Sayed, Steven Shoptaw, Chelsea L. Shover, Michelle Tabajonda, Yvonne S. Yang, Nina T. Harawa
Abstract
Long-acting injectable antiretroviral medications are new to HIV treatment. People with HIV may benefit from a treatment option that better aligns with their preferences, but could also face new challenges and barriers. Authors from the fields of HIV, substance use treatment, and mental health collaborated on this commentary on the issues surrounding equitable implementation and uptake of LAI ART by drawing lessons from all three fields. We employ a socio-ecological framework beginning at the policy level and moving through the community, organizational, interpersonal, and patient levels. We look at extant literature on the topic as well as draw from the direct experience of our clinician-authors.